Skip to content

Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial

Photo

Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial — Eplontersen shows benefit in transthyretin amyloid cardiomyopathy only without stabilizers

Used in

Eplontersen shows benefit in transthyretin amyloid cardiomyopathy only without stabilizers en